Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for HS-10374 evaluating efficacy and safety in mild-to-moderate plaque psoriasis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HS-10374

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING